U.S. Tobacco Stock News

NYSEAM:IE
NYSEAM:IEMetals and Mining

Ivanhoe Electric (IE) On Whether Its Earnings Miss Leaves The Stock Fully Valued

Ivanhoe Electric (IE) has drawn fresh attention after reporting second quarter 2026 results, with revenue and earnings per share coming in below analyst expectations and investors focusing on management’s latest commentary. See our latest analysis for Ivanhoe Electric. The latest earnings miss comes after a mixed year for Ivanhoe Electric, with the share price up 20.7% over the past month but down 32.6% year to date and a 3 year total shareholder return that remains weak at 32.18% decline...
NasdaqGS:ONC
NasdaqGS:ONCBiotechs

BeOne Medicines (ONC) Stock Looks Strong On Returns But Above Fair Value

BeOne Medicines stock has delivered a strong 76.2% return over the past three years, yet current valuation checks and market multiples point to a company that screens on the expensive side rather than as an obvious bargain. Over the past three years, BeOne Medicines has returned 76.2%, which puts added pressure on today’s buyers to judge whether that share price gain already reflects much of the good news. The recent UK Innovation Passport for its liver cancer bispecific can support...
NYSE:IVZ
NYSE:IVZCapital Markets

Invesco (IVZ) Could Be 4% Undervalued After Q2 Earnings】【”】【

Q2 earnings highlight Invesco’s latest performance shift Invesco (IVZ) has just reported second quarter 2026 results, providing an updated snapshot of how the asset manager is performing and what that might mean for the stock. The company reported Q2 revenue of US$1,825.6 million, compared with US$1,515.5 million in the same quarter a year earlier. Net income was US$382.3 million, compared with US$203.4 million a year ago. Basic earnings per share from continuing operations were US$0.77,...
NasdaqGS:CHEF
NasdaqGS:CHEFConsumer Retailing

Chefs' Warehouse (CHEF) Stock Looks Reasonable On Cash Flow But Rich On Earnings

Chefs' Warehouse stock has delivered a very large 270.7% return over the past five years, yet the current valuation checks send mixed signals. An intrinsic value estimate from a Discounted Cash Flow (DCF) model points to upside, while earnings-based multiples appear expensive. After a strong run, the stock now sits at the center of a valuation debate rather than looking clearly cheap or clearly overvalued. Over five years, Chefs' Warehouse has returned 270.7%, which puts extra focus on...
NYSE:CRS
NYSE:CRSAerospace & Defense

What Does Carpenter Technology (CRS) CEO Brian Malloy's Death Mean For Investors?

Carpenter Technology (NYSE: CRS) announced the sudden passing of CEO and President Brian Malloy. The board re-appointed Executive Chairman Tony Thene as CEO, effective immediately. The leadership change raises new questions about Carpenter Technology's direction and execution plans. Investors are evaluating what this transition could mean for governance, capital allocation and long-term priorities. For a wider view of how leadership and execution quality can influence outcomes across...
NasdaqGS:LQDT
NasdaqGS:LQDTCommercial Services

Why Liquidity Services (LQDT) Is Up 7.9% After Raising Q4 Earnings Guidance And What's Next

Earlier this week, Liquidity Services, Inc. reported third-quarter 2026 results showing year-on-year growth in sales to US$81.84 million, revenue to US$129.58 million, and net income to US$10.43 million, alongside higher earnings per share from continuing operations. For the first nine months of fiscal 2026, the company kept sales essentially flat while lifting revenue and earnings, and it issued fiscal fourth-quarter guidance for GAAP net income of US$10.0 million to US$13.0 million and...
NasdaqGS:ALMR
NasdaqGS:ALMRLife Sciences

Alamar Biosciences (ALMR) Introduced Its NULISAseq Immune 340 Panel

Alamar Biosciences (NasdaqGS: ALMR) announced the launch of its NULISAseq Immune 340 Panel, aimed at profiling hard to measure immune system proteins across multiple disease areas. The company expanded its partnership with ALZpath to advance blood based diagnostics for Alzheimer's disease using ALZpath's phosphorylated tau 217 (pTau217) antibody. Management positions the two updates as strengthening Alamar's role in translational research, drug development, and precision medicine...
NYSE:AJG
NYSE:AJGInsurance

Should Arthur J. Gallagher’s Expanded M&A Firepower and Capital Returns Strategy Require Action From AJG Investors?

Arthur J. Gallagher & Co. has already reported its second-quarter 2026 results, showing revenue rising to US$4.00 billion while quarterly net income declined to US$324 million, alongside ongoing share repurchases, a maintained US$0.70 dividend, and board changes following the passing of its Lead Independent Director. The company also highlighted roughly US$10.00 billion of capital deployment capacity over the next two years, with a strong M&A pipeline supported by significant tax-related...
NYSE:PPL
NYSE:PPLElectric Utilities

PPL (PPL) Stock Climbs As Premium Valuation Meets Funding Strain

PPL stock was already grinding through a soft patch, down over the past month and quarter, yet it popped about 2.4% to US$35.46 after the latest earnings. The market reacted positively in the near term. The company reported Q2 ongoing earnings per share that aligned with its plan and kept full-year guidance intact. The real story for long-term holders is not this quarter’s modest utilities-style EPS. It is the tension between a richer P/E multiple, a capital-heavy expansion plan, and balance...
NasdaqGS:NVMI
NasdaqGS:NVMISemiconductor

Nova (NVMI) Q2 Earnings And AI Packaging Demand Put Valuation Back In Focus

How Nova’s latest earnings and guidance tie back to AI demand Nova (NasdaqGS:NVMI) is back in focus after record Q2 2026 results and fresh Q3 guidance highlighted AI linked advanced packaging as a key operational driver for the business. The company reported Q2 revenue of US$254.96 million and net income of US$75.01 million, alongside management commentary that pointed to AI related demand as central to the performance and near term outlook. See our latest analysis for Nova. Despite the...
NYSE:VRT
NYSE:VRTElectrical

Vertiv (VRT) Is Up 12.8% After Raised 2026 Guidance And New AI Data Center Partnership

In late July and early August 2026, Vertiv Holdings Co reported higher second-quarter revenue and earnings, raised its 2026 guidance, completed a roughly US$599.84 million buyback program, and Bitzero Holdings Inc. announced a collaboration with Vertiv to support AI and high-performance computing data centers with advanced power and liquid-cooling infrastructure. This combination of stronger reported performance, higher management expectations, and a deepening role in AI-focused data center...
NYSE:OGS
NYSE:OGSGas Utilities

Target Stock Leads Defensive Dividend Ideas After Weak Jobs Data

Fresh jobs data showing a surprise loss of 23,000 U.S. roles in July and a softer labor force is pushing investors to rethink where steady income might come from next. With the Federal Reserve now more likely to sit tight or turn more cautious on rates, dividend income stocks are back in focus. This article walks through three large cap dividend stocks that appear closely tied to this shifting jobs story. The three stocks below are just a starting sample, and the full screen surfaced 23 more...
NYSE:LTC
NYSE:LTCHealth Care REITs

How LTC’s Raised 2026 Guidance And SHOP Expansion At LTC Properties (LTC) Has Changed Its Investment Story

In early August 2026, LTC Properties reported second-quarter revenue of US$98.86 million and net income of US$29.64 million, raised full-year 2026 earnings guidance, accelerated growth of its SHOP senior housing platform to over US$1.30 billion in gross investments, and completed US$311.40 million of at-the-market equity issuance to fund acquisitions. The rapid expansion of LTC’s younger-age SHOP portfolio, largely through external acquisitions supported by fresh equity capital, marks a...
NYSE:CBL
NYSE:CBLRetail REITs

CBL (CBL) Stock Rises On Stronger FFO Despite One Off Boosts

The market pushed CBL & Associates Properties up 4.1% to US$56.55, even though the headline Q2 story is quieter than that price move suggests. For a retail REIT, the key yardstick is Funds From Operations, and FFO for the quarter sits at US$59.9m on revenue of US$146.5m. The trailing picture shows earnings that are flattered by a very large one off gain. Yet the stock still trades on a low trailing P/E of 8.2x. That mix of emotional buying and complicated fundamentals sets the stage for a...
NasdaqGM:TNDM
NasdaqGM:TNDMMedical Equipment

Why Tandem Diabetes Care (TNDM) Is Up 14.8% After Reaffirming 2026 Outlook And Highlighting Mobi Momentum

In early August 2026, Tandem Diabetes Care reported second-quarter 2026 results showing sales of US$254.56 million, a reduced net loss of US$21.17 million, and significantly lower basic loss per share compared with the same period a year earlier. The company also reaffirmed its full-year 2026 sales outlook of US$1.07–1.09 billion while highlighting early traction of its Pay-As-You-Go pharmacy model, growing Mobi platform adoption, and progress toward FDA clearance for new tubeless...
NasdaqGS:CASY
NasdaqGS:CASYConsumer Retailing

Casey's General Stores (CASY) Could Be 12% Undervalued As Margin Gains Shape The Story

Recent performance context for Casey's General Stores With no single headline event driving recent attention, Casey's General Stores (CASY) is drawing interest as the stock price sits near US$833.95 and the company reports annual revenue of about US$17.6b and net income of roughly US$714.4m. See our latest analysis for Casey's General Stores. Over the past year, Casey's General Stores has combined a strong share price run with periods of consolidation, including a 49.92% year to date share...
NYSE:SVV
NYSE:SVVMultiline Retail

Savers Value Village (SVV) Is Up 19.1% After Launching ThriftIQ AI Pricing Platform And Raising Guidance

In early August 2026, Savers Value Village reported higher second-quarter sales and earnings and introduced ThriftIQ, an AI-enabled pricing platform that has already priced more than 25 million apparel items across 58 pilot stores. The company highlighted that ThriftIQ, built on one of North America’s largest secondhand goods datasets, is improving sell-through, basket size, and pricing consistency while keeping average prices 40–70% below traditional retail. Next, we’ll examine how...
NasdaqGS:LYFT
NasdaqGS:LYFTTransportation

Lyft (LYFT) On Q2 Results And Autonomous Deals Has A Modestly Undervalued Narrative

Lyft (LYFT) is back in focus after reporting second quarter 2026 results on 6 August. The update gives investors fresh numbers on sales, profitability, rider trends, and its evolving ride sharing platform. See our latest analysis for Lyft. The earnings beat and news on autonomous partnerships have pushed Lyft’s short term share price return higher, with a 1 day move of 7.12% and a 90 day share price return of 25.88%. Yet year to date the share price return has declined 11.77%, while the 1...
NasdaqGS:SAIC
NasdaqGS:SAICProfessional Services

Can Science Applications International (SAIC) Justify Its Valuation After New Defense Contract Wins?

Science Applications International (SAIC) recently announced a $400 million recompete contract with a U.S. Intelligence Agency, along with a $70 million U.S. Navy radar task order. These deals underscore fresh contract momentum in government and defense work. See our latest analysis for Science Applications International. These fresh contract wins come as Science Applications International shares trade at US$126.54, with a 90-day share price return of 36.58% and a 5-year total shareholder...
NYSE:JILL
NYSE:JILLSpecialty Retail

3 US Consumer Discretionary Stocks With Low P E Ratios In Focus

Cooling US inflation, a softer Fed outlook and steady consumer spending are quietly reshaping the opportunity set in consumer discretionary stocks. When price pressures ease and borrowing costs look less threatening, some companies tied to travel, leisure and retail can find themselves in a sweet spot, while others may struggle to keep up. This article explains how that story links to 3 stocks from our screener and what that could mean for your portfolio decisions. The stocks highlighted...
NYSE:ASIX
NYSE:ASIXChemicals

AdvanSix (ASIX) Stock Sinks As Margin Pressure Clouds Profit Recovery

AdvanSix investors woke up to an 18% one day hit, with the stock sliding from US$20.14 to US$16.48, even as the latest quarter quietly flipped back into the black. The company posted Q2 2026 basic earnings per share of about US$0.12 on revenue of US$421.3m, a sharp contrast to the loss reported in Q1. The market is trading the trailing pain. The numbers tell a different story, centered on a profit squeeze that has eased but not disappeared. That tension between a bruised share price and a...
NYSE:MPLX
NYSE:MPLXOil and Gas

Is Revenue Growth And Steady Payout Altering The Investment Case For MPLX (MPLX)?

In early August 2026, MPLX LP reported past second-quarter 2026 results showing higher sales of US$3,082 million and revenue of US$3,312 million versus a year earlier, modestly higher quarterly net income of US$1,077 million, and maintained its quarterly cash distribution of US$1.0765 per common unit. Alongside ongoing share repurchases under its 2022 buyback authorization and management’s renewed interest in inorganic opportunities, the combination of revenue growth, steady earnings per...
NasdaqCM:SATL
NasdaqCM:SATLAerospace & Defense

Satellogic (SATL) Could Be 45% Undervalued After Revenue Jump And Wider Losses

Why Satellogic Stock Is Back on Investors’ Radar Satellogic (SATL) has drawn fresh interest after reporting second quarter and first half 2026 results on 5 August, with higher revenue figures alongside wider losses catching the attention of investors. The company posted second quarter revenue of US$15.92 million, compared with US$4.44 million a year earlier. Net loss widened to US$20.05 million from US$6.65 million. Basic loss per share from continuing operations was US$0.13, compared with...
NasdaqCM:ASTH
NasdaqCM:ASTHHealthcare

Astrana Health (ASTH) On Earnings And Deal Plans Is It A Buying Opportunity

Astrana Health earnings, guidance and acquisition plans come into focus Astrana Health (ASTH) is back on investor radars after its second quarter 2026 earnings, fresh revenue and net income guidance, and comments about ongoing tuck in acquisitions in key expansion markets. See our latest analysis for Astrana Health. Astrana Health's latest guidance and acquisition plans come after a sharp share price pullback, with a 30 day share price return down 23.71%, even though the year to date share...